Structured Summary
Abstract
The biologically active fragment of human growth hormone-releasing factor, consisting of GHRH(1-29)-amide. This N-terminal sequence is identical in several mammalian species, such as human, pig, and cattle. It is used to diagnose or treat patients with GROWTH HORMONE deficiency.
MeSH Record
Classification
Broader headings
Related Concepts
Knowledge Graph
Drag nodes to rearrange; hover to trace links; click a node to open its page.
MeSH Record
Synonyms
7 entry terms
- GHRH(1-29)NH2
- GRF(1-29)NH2
- Growth Hormone-Releasing Factor(1-29)Amide
- Somatotropin-Releasing-Hormone(1-29)Amide
- hGHRH(1-29)NH2
- Geref
- Sermorelin Acetate
MeSH Record
Aspects Covered
25 allowable subheadings
Indexed with the subheadings administration & dosage, adverse effects, agonists, analogs & derivatives, analysis, antagonists & inhibitors, blood, cerebrospinal fluid, chemical synthesis, chemistry, classification, economics, history, immunology, isolation & purification, metabolism, pharmacokinetics, pharmacology, poisoning, radiation effects, standards, supply & distribution, therapeutic use, toxicity, urine.
MeSH Record
History Note
93; was SOMATOTROPIN RELEASING HORMONE(1-29)AMIDE (NM) 1984-92
MeSH Record
Previous Indexing
- Peptide Fragments (1984-1992)
- Somatotropin-Releasing Hormone/analogs & derivatives (1984-1992)
MeSH Hierarchy
Tree Numbers
AMA Style
References
- National Library of Medicine. Sermorelin. Medical Subject Headings (MeSH). 2026. Unique ID D017337. http://id.nlm.nih.gov/mesh/2026/D017337
- Sermorelin. In: Wikipedia. https://en.wikipedia.org/wiki/Sermorelin
- Sermorelin. In: Wikidata. https://www.wikidata.org/wiki/Q7455005